Patent ID: 8977365
Filing Date: 2015-03-10
Classification: A61N

Abstract:
1. An electronic system activatable by electrical power and structured to inhibit proliferation of cancerous cells or to kill cancerous cells harboured by a warm-blooded mammalian subject, said electronic system comprising at least one controllable low energy electromagnetic energy generator circuit for generating one or more high frequency carrier signals, at least one data processor constructed and arranged for communication with the at least one generator circuit and for receiving control information from a source of control information, said at least one generator circuit including at least one amplitude modulation control signal generator for controlling amplitude modulated variations of the one or more high frequency carrier signals, said at least one generator circuit furthermore including at least one programmable amplitude modulation frequency control signal generator for controlling frequencies at which amplitude modulations are generated, the system furthermore comprising a connection position for connection to an electrically conductive applicator for applying to the warm-blooded mammalian subject one or more amplitude-modulated low energy emissions at a program-controlled frequency, wherein said at least one programmable amplitude frequency control generator is adapted to accurately control the frequencies at which said amplitude modulations are generated to within an accuracy of at least 1000 parts per million relative to determined or predetermined reference amplitude modulation frequencies selected from within a range of 0.01 Hz to 150 kHz and wherein said source of control information includes reference amplitude modulation frequency control information which comprises a selection of from at least a proportion in excess of 50% to all of reference amplitude modulation frequencies accurately defined for a type of the cancerous cells to be inhibited in proliferation or killed, wherein said selection of the reference amplitude modulation frequencies accurately defined comprised in said source control information is made dependent on the type of cancerous cells to be inhibited in proliferation or killed identified as set forth in combination with listings of the reference amplitude modulation frequencies accurately defined as follows: (1) frequencies for treatment of breast cancer as follows (2) frequencies for treatment of hepatocellular carcinoma (liver cancer) as follows (3) frequencies for treatment of ovarian cancer as follows (4) frequencies for treatment of prostate cancer as follows (5) frequencies for treatment of kidney cancer as follows (6) frequencies for treatment of thyroid cancer as follows (7) frequencies for treatment of bladder cancer as follows (8) frequencies for treatment of colon cancer as follows (9) frequencies for treatment of pancreas cancer as follows (10) frequencies for treatment of lung cancer as follows (11) frequencies for treatment of leiomyosarcoma as follows (12) frequencies for treatment of mesothelioma as follows (13) frequencies for treatment of neuro-endocrine as follows (14) frequencies for treatment of leukemia and chronic lymphoid cancer as follows (15) frequencies for treatment of myeloma as follows (16) frequencies for treatment of lymphoma as follows and (17) frequencies for treatment of brain cancer as follows